Complexed PSA performance for prostate cancer detection in an African-American population
- 1 November 2003
- Vol. 62 (5) , 835-839
- https://doi.org/10.1016/s0090-4295(03)00675-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancerUrology, 2002
- Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterUrology, 2002
- Comparative Analysis of Complexed Prostate Specific Antigen, Free Prostate Specific Antigen and Their Ratio in Detecting Prostate CancerJournal of Urology, 2002
- Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen eraCancer, 2001
- COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCERJournal of Urology, 2000
- USE OF LOWER PROSTATE SPECIFIC ANTIGEN CUTOFFS FOR PROSTATE CANCER SCREENING IN BLACK AND WHITE MENJournal of Urology, 1998
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Prevalence and Predictors of a Positive Repeat Transrectal Ultrasound Guided Needle Biopsy of the ProstateJournal of Urology, 1997
- Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA, 1997
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987